# Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes

> **NCT05076292** · NA · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 22 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** GlucaGen
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05076292
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-23
- **Primary completion:** 2023-08-08
- **Final completion:** 2023-08-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05076292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05076292, "Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05076292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*